Associated Papers
Impact of UGT1A4 Polymorphisms on the Posaconazole Serum Trough Concentrations in Patients With Acute Myeloid Leukemia Receiving Delayed-Release Tablets.
Parant F et al.
Therapeutic Drug Monitoring, 2025
Pharmacogenetic Variation in Over 100 Genes in Patients Receiving Acenocumarol.
Gonzalez-Covarrubias V et al.
Frontiers in Pharmacology, 2017
29218011 (PubMed )
Supplement: Table1.XLSX › ST1_targetgenes
Pharmacogenetics of UGT1A4, UGT2B7 and UGT2B15 and Their Influence on Tamoxifen Disposition in Asian Breast Cancer Patients.
Sutiman N et al.
Clinical Pharmacokinetics, 2016
A pharmacogenetics study of the human glucuronosyltransferase UGT1A4.
Benoit-Biancamano MO et al.
Pharmacogenetics and Genomics, 2009
Analysis of inherited genetic variations at the UGT1 locus in the French-Canadian population.
Ménard V et al.
Human Mutation, 2009
UDP-glucuronosyltransferase 1A4 polymorphisms in a Japanese population and kinetics of clozapine glucuronidation.
Mori A et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals, 2005
Genetic variations and haplotypes of UGT1A4 in a Japanese population.
Saeki M et al.
Drug Metabolism and Pharmacokinetics, 2005
Select a paper to view details